Sponsor or institution
Clinical trials and research at Beijing Mabworks Biotech Co., Ltd.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Beijing Mabworks Biotech Co., Ltd. that are recruiting, in China. By phase: Phase 1/2 (3), Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Phase 3 MIL62 treatment for systemic lupus erythematosus | Phase 3 | Beijing | Recruiting | Feb 12, 2026 |
| MIL116 for people with IgA nephropathy and healthy volunteers | Phase 1/2 | Beijing | Recruiting | Jan 29, 2026 |
| Evaluating MBS314 for patients with relapsed or refractory multiple myeloma | Phase 1/2 | Beijing | Recruiting | Jan 30, 2024 |
| Evaluating a new treatment for B-Cell Non-Hodgkin's Lymphoma | Phase 1/2 | Beijing | Recruiting | Apr 10, 2023 |
| Treatment for advanced and metastatic solid tumors using MIL97 | Phase 1 | Beijing, Beijing Municipality | Recruiting | Jul 16, 2021 |
All recruiting trials (5)
-
Phase 3 MIL62 treatment for systemic lupus erythematosus
This study will test whether MIL62 is more effective and safe than placebo for adults with active systemic lupus erythematosus.
-
MIL116 for people with IgA nephropathy and healthy volunteers
This trial will test whether subcutaneous MIL116, an anti‑APRIL antibody, is safe and how it behaves in the body in adults with IgA nephropathy and in healthy volunteers.
-
Evaluating MBS314 for patients with relapsed or refractory multiple myeloma
This study is testing a new treatment called MBS314 to see if it can help people with relapsed or refractory multiple myeloma feel better.
-
Evaluating a new treatment for B-Cell Non-Hodgkin's Lymphoma
This study is testing a new treatment called MBS303 to see if it can help people with relapsed or hard-to-treat B-Cell Non-Hodgkin's Lymphoma feel better and respond well to the therapy.
-
Treatment for advanced and metastatic solid tumors using MIL97
This study is testing a new treatment called MIL97 to see if it can safely help people with advanced or metastatic solid tumors.
Quick answers
How many clinical trials run by Beijing Mabworks Biotech Co., Ltd. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.